Clinical Trial Update: A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of paclitaxel-eluting balloon compared with paclitaxel-eluting stent for coronary in-stent restenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary In-stent Restenosis

Drugs mentioned

• Paclitaxel-eluting balloon (paclitaxel)
• Paclitaxel-eluting stent (paclitaxel-eluting stent)

Snippet

Sponsor: B. Braun Medical International Trading Company Ltd. | Conditions: Coronary Instent Restenosis | Phase 3 | Status: COMPLETED